SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Illumina (ILMN) Optics for Genomics
An SI Board Since July 2000
Posts SubjectMarks Bans Symbol
276 43 0 ILMN
Emcee:  Elmer Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
251Illumina Launches cBot, a Breakthrough Workflow Automation System for Next GenerA.J. Mullen-10/20/2009
250Illumina Announces Delivery of the First Genome Through Its Individual Genome SeArthur Radley-8/31/2009
249Commentary 2009 Aug 26, Lee Schwartzberg, MD, PhD, Editor-in-Chief Old paradigArthur Radley-8/26/2009
248reuters.com News like this will only add to the potential for ILMN....IMO! I wiArthur Radley-8/25/2009
247Illumina second-quarter profit nearly doubles on new products; adjusted results tnsaf-7/22/2009
246NGS - there is a tough competition but so far Illumina leads the pack. <b>idos-7/3/2009
245Analyst color on yesterday's negative earnings preannouncement: notablecalltuck-7/2/2009
244{Forbes take on the news) Genomes! Get Your Genomes! Just $50K Matthew Herper, 0A.J. Mullen-6/11/2009
243Yes, I'm sure you're right. I have no problem with a high-priced introdA.J. Mullen-6/11/2009
242Price will drop in a few years time to $1000 per genome.idos-6/11/2009
241That's a big change of direction - from selling machines to labs to selling A.J. Mullen-6/11/2009
240ILMN is launching a consumer sequencing service: <b>Genomes! Get Your Genidos-6/11/2009
239An impressive order: <b>Illumina shares gain ground as MIT, Harvard partnidos-4/16/2009
238ILMN announced the launch of the GA-IIx upgrade which will increase read lengthsidos-2/6/2009
237ILMN pointed out during the call that their stock-based compensation expense is CrazyPete-10/23/2008
236Looks like that despite having strong business the market doesn't believe thidos-10/23/2008
235Motely Fool's analysis - stock options make the difference: (http://www.fooA.J. Mullen-10/22/2008
234THanks- eomA.J. Mullen-10/22/2008
233Sales were indeed ok but EPS was below consensus.idos-10/22/2008
232Earnings seemed OK to me and the conference call comfortable, so why did the stoA.J. Mullen-10/22/2008
231Illumina Q3 Earnings Call transcript: seekingalpha.comA.J. Mullen-10/22/2008
230Nearby tissue reveals liver cancer recurrence risk Wed Oct 15, 2008 5:00pm EDT A.J. Mullen-10/15/2008
229Illumina Inc. Q2 2008 Earnings Call Transcript seekingalpha.comA.J. Mullen-7/23/2008
228<i>Three news releases today</i> <b>Illumina board approves 2tnsaf-7/22/2008
227Nice contract for ILMN: biz.yahoo.com The Wellcome Trust Case Control Consortiidos-7/1/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):